Thoracic Medicine, Concord Hospital, Concord, New South Wales, Australia.
Faculty of Medicine and Health, The University of Sydney, Camperdown, New South Wales, Australia.
Physiol Rep. 2023 Apr;11(7):e15660. doi: 10.14814/phy2.15660.
Reduced carbon monoxide diffusing capacity (DL ) is common after recovery from severe COVID-19 pneumonitis. The extent to which this relates to alveolar membrane dysfunction as opposed to vascular injury is uncertain. Simultaneous measurement of nitric oxide diffusing capacity (DL ) and DL can partition gas diffusion into its two components: alveolar-capillary membrane conductance (D ) and capillary blood volume (V ). We sought to evaluate D and V in the early and later recovery periods after severe COVID-19. Patients attended for post-COVID-19 clinical review and lung function testing including DL /DL . Repeat testing occurred when indicated and comparisons made using t-tests. Forty-nine (eight female) subjects (mean ± SD age: 58 ± 13, BMI: 34 ± 8) who had severe COVID-19 pneumonitis, WHO severity classification of 6 ± 1, and prolonged (21 ± 22 days) hospital stay, were assessed 2 months (61 ± 35 days) post discharge. DL adj (z-score -1.70 ± 1.49, 25/49 < lower limit of normal [LLN]) and total lung capacity (z-score -1.71 ± 1.30) were both reduced. D and V and were reduced to a similar extent (z-score -1.19 ± 1.05 and -1.41 ± 1.20, p = 0.4). Seventeen (one female) patients returned for repeat testing 4 months (122 ± 61 days) post discharge. In this subgroup with more impaired lung function, DL adj improved but remained below LLN (z-score -3.15 ± 0.83 vs. -2.39 ± 0.86, p = 0.01), 5/17 improved to >LNN. D improved (z-score -2.05 ± 0.89 vs. -1.41 ± 0.78, p = 0.01) but V was unchanged (z-score -2.51 ± 0.55 vs. -2.29 ± 0.59, p = 0.16). Alveolar membrane conductance is abnormal in the earlier recovery phase following severe COVID-19 but significantly improves. In contrast, reduced V persists. These data raise the possibility that persisting effects of acute vascular injury may contribute to gas diffusion impairment long after severe COVID-19 pneumonitis.
一氧化碳弥散量(DL )降低在严重 COVID-19 肺炎恢复后很常见。但尚不清楚这与肺泡膜功能障碍相比,与血管损伤的关系如何。一氧化氮弥散量(DL )和 DL 的同时测量可以将气体弥散分为两个组成部分:肺泡-毛细血管膜导度(D )和毛细血管血容量(V )。我们旨在评估严重 COVID-19 后的早期和晚期恢复期间的 D 和 V 。患者参加 COVID-19 后临床复查和肺功能测试,包括 DL /DL 。当需要时进行重复测试,并使用 t 检验进行比较。评估了 49 名(8 名女性)患有严重 COVID-19 肺炎、世界卫生组织严重程度分类为 6 级和延长(21±22 天)住院时间的患者,出院后 2 个月(61±35 天)进行了评估。DL adj (z 分数-1.70±1.49,25/49<正常下限[LLN])和总肺容量(z 分数-1.71±1.30)均降低。D 和 V 降低到相似的程度(z 分数-1.19±1.05 和-1.41±1.20,p=0.4)。17 名(1 名女性)患者在出院后 4 个月(122±61 天)重复测试。在肺功能更受损的亚组中,DL adj 改善但仍低于 LLN(z 分数-3.15±0.83 与-2.39±0.86,p=0.01),5/17 改善至>LLN。D 改善(z 分数-2.05±0.89 与-1.41±0.78,p=0.01),但 V 不变(z 分数-2.51±0.55 与-2.29±0.59,p=0.16)。肺泡膜导度在严重 COVID-19 后的早期恢复阶段异常,但显著改善。相比之下,V 降低持续存在。这些数据提示,急性血管损伤的持续影响可能导致严重 COVID-19 肺炎后很长时间气体弥散受损。